PTGR1 blocking peptide product blog
Tags: Blocking Peptide; PTGR1; PTGR1 blocking peptide;
The PTGR1 ptgr1 (Catalog #MBS9225857) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The PTGR1 ptgr1 product has the following accession number(s) (GI #226059159) (NCBI Accession #NP_001139580.1) (Uniprot Accession #Q14914). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4.
Cellular Location: Cytoplasm. Tissue Location: High expression in the kidney, liver, and intestine but not in leukocytes. The following patways have been known to be associated with this gene. Adipose Tissue, Bladder, Bone, Brain, Intestine, Liver, Lung, Mouth, Muscle, Prostate tissues are correlated with this protein. Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, Inflammation, Liver Diseases, Liver Neoplasms, Lung Diseases, Neoplasms, Experimental, Pain, Urinary Bladder Neoplasms are some of the diseases may be linked to PTGR1 Antibody (Center) Blocking peptide.